2005
DOI: 10.1016/j.jaut.2004.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis B vaccination and central nervous system demyelination: an immunological approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 26 publications
(14 reference statements)
0
11
0
1
Order By: Relevance
“…The main risk period considered was 3 years to facilitate comparison with the study by Hernán et al 9 We also investigated longer risk periods, including the entire period from birth to the index date, inasmuch as the duration of the true risk period is unknown, as is the time course of white matter and axonal destruction in MS after stimulation with external antigens such as vaccines. 26,27 We found no increase in the risk of MS associated with HBV exposure during childhood irrespective of the risk period studied and of the number of doses administered. The upper boundary of the 95% CI indicates that increase in risk by a factor of 1.7 or higher (for the 3-year period and for the indefinite period) could be excluded, with higher statistical power than in previous studies.…”
Section: Commentmentioning
confidence: 66%
“…The main risk period considered was 3 years to facilitate comparison with the study by Hernán et al 9 We also investigated longer risk periods, including the entire period from birth to the index date, inasmuch as the duration of the true risk period is unknown, as is the time course of white matter and axonal destruction in MS after stimulation with external antigens such as vaccines. 26,27 We found no increase in the risk of MS associated with HBV exposure during childhood irrespective of the risk period studied and of the number of doses administered. The upper boundary of the 95% CI indicates that increase in risk by a factor of 1.7 or higher (for the 3-year period and for the indefinite period) could be excluded, with higher statistical power than in previous studies.…”
Section: Commentmentioning
confidence: 66%
“…HBV aşısının santral sinir sistemi demyelinizasyonuna yol açtığı ve multipl skleroz oluşturduğu yada alevlendirdiğini bildiren bazı çalışmalar olmakla birlikte yapılan çok sayıda geniş kapsamlı toplum tabanlı epidemiyolojik çalışmalar HBV aşısının multipl skleroz gelişme riskini ya da alevlenmesini arttırmadığını ve arada bir nedensellik ilişkisi bulunmadığı düşündürmektedir. Bu nedenle de bu konuda daha geniş kapsamlı çalışmalar yapılması gerektiği belirtilmektedir (73)(74)(75)(76)(77)(78)(79).Erişkinlerdeki aşı yan etkilerinin kayıtlarının (VAERS) değerlendirildiği bir çalışmada 1991-2000 yılları arasında aşılanan erişkinlerin 1997-2000 yılları arasındaki aşı yan etki kayıtları incelenmiştir. Bu çalışmanın sonucunda HBV aşısına bağlı yan etkiler konusunda herhangi bir bilimsel kanıt sağlanamamış olup yine de aşı uygulanacak kişilerin hekimler tarafından bu konularla ilgili olarak bilgilendirilmesi gerektiği sonucuna varılmıştır (80).…”
Section: Kombine Aşılarunclassified
“…Distribution of the vaccine indeed lead to a dramatic reduction in HBV complications in countries that have implemented large-scale vaccination programs [85], but large series of autoimmune adverse events have been reported in the scientific literature after this vaccine [84,86]. The autoimmune adverse events include: SLE, Guillain-Barre' syndrome, rheumatic disorders, uveitis, lichen rubber planus, nephritic syndrome, CNS demyelinization and relapsing MS [85,[87][88][89].…”
Section: Hepatitis B Vaccination and Autoimmunitymentioning
confidence: 99%
“…The autoimmune adverse events include: SLE, Guillain-Barre' syndrome, rheumatic disorders, uveitis, lichen rubber planus, nephritic syndrome, CNS demyelinization and relapsing MS [85,[87][88][89]. Hepatitis B vaccination could break self-tolerance and induce autoimmune adverse events by synergistic interaction between the immunological stimulatory components of the immunization (including: the HBsAg, aluminum adjuvant, mercury preservative and residual yeast proteins) in a genetically susceptible vaccine recipient, within fairly close temporal association with vaccine administration [84].…”
Section: Hepatitis B Vaccination and Autoimmunitymentioning
confidence: 99%
See 1 more Smart Citation